Gene Expression Regulation, Enzymologic
"Gene Expression Regulation, Enzymologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis.
| Descriptor ID |
D015971
|
| MeSH Number(s) |
G05.308.320
|
| Concept/Terms |
Gene Expression Regulation, Enzymologic- Gene Expression Regulation, Enzymologic
- Regulation of Gene Expression, Enzymologic
- Regulation, Gene Expression, Enzymologic
- Enzymologic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Enzymologic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Enzymologic".
This graph shows the total number of publications written about "Gene Expression Regulation, Enzymologic" by people in this website by year, and whether "Gene Expression Regulation, Enzymologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 4 | 6 |
| 2017 | 10 | 23 | 33 |
| 2018 | 6 | 16 | 22 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 7 | 8 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Gene Expression Regulation, Enzymologic" by people in Profiles.
-
Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L. PLoS One. 2021; 16(8):e0256141.
-
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19? Adv Biol Regul. 2021 08; 81:100820.
-
Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro. FASEB J. 2021 08; 35(8):e21774.
-
Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection. Curr Opin Lipidol. 2021 08 01; 32(4):266-267.
-
ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2. J Virol. 2021 07 12; 95(15):e0032721.
-
Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2. Aging (Albany NY). 2021 07 06; 13(13):16904-16921.
-
Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2. Genes (Basel). 2021 07 05; 12(7).
-
Clinical and in Vitro Evidence against Placenta Infection at Term by Severe Acute Respiratory Syndrome Coronavirus 2. Am J Pathol. 2021 09; 191(9):1610-1623.
-
Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Am J Pathol. 2021 09; 191(9):1511-1519.
-
ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol. Invest Ophthalmol Vis Sci. 2021 06 01; 62(7):25.